Read our article in the medical journal DeviceMed
With our Regulatory Affairs Software REGULA™ daily RA activities can be greatly simplified. This increases efficiency and shortens the time to market, which finally results in more turnover. This article was one of the most read DeviceMed articles in November 2016.
We consider each REGULA™ introduction as a project and for each introduction we work through the following steps:
REGULA™ is not just a software, it is a project. Based on foreign projects the cost constellation is as follows:
The recurring costs are calculated on the initial investment and on other factors: